This trial aims to investigate whether tampons can be used to diagnose a range of common vaginal infections (HPV, BV, chlamydia and gonorrhoea).
Developing an effective and user-friendly way of testing for these infections using tampons could significantly improve women's health outcomes. As many women already use tampons on a monthly basis, using them in this way could increase testing uptake and enhance early detection and treatment of infections.
You will be compensated £50 for full participation in the study as well as reasonable travel expenses.
Tampon Innovations which is a subsidiary of DAYE
325
People
Personen
February 16, 2024
16.2.2024
16.2.2024
16.2.2024
This trial aims to investigate whether tampons can be used to diagnose a range of common vaginal infections (HPV, BV, chlamydia and gonorrhoea).
Developing an effective and user-friendly way of testing for these infections using tampons could significantly improve women's health outcomes. As many women already use tampons on a monthly basis, using them in this way could increase testing uptake and enhance early detection and treatment of infections.
You will be compensated £50 for full participation in the study as well as reasonable travel expenses.
Women aged 25-65
Tampon Innovations which is a subsidiary of DAYE
325
People
Personen
February 16, 2024
16.2.2024
16.2.2024
16.2.2024
Women who:
>Are aged 25-65
>Tested positive for HPV in the last month (need records to confirm)
>Willing to attend one in-person clinic visit at either Manor Place Surgery, 1 Manor Place, London, SE17 3BD or Princess Street Practice, 2 Princess Street, London, SE1 6JP
>Are not pregnant or breastfeeding
>Are not participating in another clinical trial
>You will be compensated £50 plus reasonable travel expenses to the clinic visit for your participation
>If you provide consent, you will also receive the results of your samples which may identify a positive HPV or STI result. Please note that these tests are experimental and you should contact your GP for medical care. Your GP will be notified in the event of a positive result if you provide consent for this communication.
>Results of this trial may lead to women having access to an easier, more convenient method of testing for STIs in the future